 |
 |
|
|
RESÚMENES JUNIO 2006 |
Addictive Disorders
(Haga un click en la
información del journal para acceder al resúmen)
Illicit
drug use and anxiety disorders: Findings from two community surveys
Jitender Sareen, Mariette Chartier,
Martin P. Paulus and
Psychiatry Research. Volume 142, Issue 1, 30 May 2006, Pages 11-17
Cannabinoids, opioids and
eating behavior: The molecular face of hedonism?
Daniela Cota, Matthias H. Tschöp, Tamas L. Horvath and Allen
S. Levine
Brain Research Reviews. Volume 51, Issue 1, June 2006, Pages
85-107
A
systematic review of the effectiveness of naltrexone
in the maintenance treatment of opioid and alcohol
dependence
Hendrik G. Roozen,
Ranne de Waart, Danielle
A.W.M. van der Windt, Wim van den Brink, Cor A.J. de Jong and Ad J.F.M. Kerkhof
European Neuropsychopharmacology. Volume 16, Issue 5, July 2006, Pages 311-323
Drug
abuse in women with eating disorders
David B.
Herzog, Debra L. Franko, David J. Dorer,
Pamela K. Keel, Safia Jackson, Mary Pat Manzo
International Journal of Eating Disorders. Volume 39, Issue 5 , Pages 364 - 368
Effect
of oral acamprosate on abstinence in patients with
alcohol dependence in a double-blind, placebo-controlled trial: The role of
patient motivation
Barbara J. Mason, Anita M. Goodman, Sylvie Chabac and Philippe Lehert
Journal of Psychiatric Research. Volume 40, Issue 5, August 2006, Pages 383-393
Functional
brain imaging of tobacco use and dependence
Arthur L. Brod
Journal of Psychiatric Research. Volume 40, Issue 5, August 2006, Pages 404-418
Nicotine
metabolite ratio predicts efficacy of transdermal
nicotine for smoking cessation
Caryn Lerman, Rachel Tyndale, Freda Patterson, E. Paul Wileyto, Peter G. Shields, Angela Pinto and Neal Benowitz
Clinical Pharmacology & Therapeutics. Volume 79, Issue 6, June 2006, Pages 600-608
Cannabis
and neurodevelopment: implications for psychiatric disorders
Suresh Sundram
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 4 ,
Pages 245 - 254
PREGABALIN IS EFFECTIVE AGAINST BEHAVIORAL
AND ELECTROGRAPHIC SEIZURES DURING ALCOHOL WITHDRAWAL
HOWARD C. BECKER, HUGH MYRICK and
LYNN M. VEATCH
Alcohol
and Alcoholism 2006 41(4):399-406
Assessment
of Agonist and Antagonist Effects of Tramadol in Opioid-Dependent Humans
C. Patrick Carroll, Sharon L. Walsh, George E.
Bigelow, Eric C. Strain and Kenzie L. Preston
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 109-120
Transdermal Nicotine-Induced Tobacco Abstinence Symptom
Suppression: Nicotine Dose and Smokers' Gender
Sarah E. Evans, Melissa Blank, Cynthia Sams, Michael F. Weaver and Thomas Eissenberg
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 121-135
Discriminative-Stimulus,
Self-Reported, Performance, and Cardiovascular Effects of Atomoxetine
in Methylphenidate-Trained Humans
Joshua A. Lile, William W.
Stoops, Todd M. Durell, Paul E.A. Glaser and Craig R.
Rush
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 136-147
A
Comparison Between Low-Magnitude Voucher and Buprenorphine Medication Contingencies in Promoting
Abstinence From Opioids and Cocaine
Anke Groß, Lisa A. Marsch, Gary J. Badger and
Warren K. Bickel
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 148-156
Methadone
Maintenance Improves Cognitive Performance After Two
Months of Treatment
Staci A. Gruber, Golfo K. Tzilos, Marisa M. Silveri, Mark
Pollack, Perry F. Renshaw, Marc J. Kaufman and
Deborah A. Yurgelun-Todd
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 157-164
Characterizing
Nicotine Withdrawal in Pregnant Cigarette Smokers
Sarah H. Heil, Stephen T. Higgins,
Joan A. Mongeon, Gary J. Badger and Ira M. Bernstein
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 165-170
Characterizing
Alcohol Dependence: Transitions During Young and
Middle Adulthood
Kristina M. Jackson, Susan E. O'Neill and Kenneth J.
Sher
Experimental and Clinical Psychopharmacology. Volume 14, Issue 2, May 2006, Pages 228-244
Thienorphine
Is a Potent Long-Acting Partial Opioid Agonist: A
Comparative Study with Buprenorphine
Gang Yu, Yong-Juan Yue, Meng-Xun Cui, and Ze-Hui Gong
Hypothalamic-Pituitary-Adrenocortical Axis Activity: A Target of Pharmacological Anticraving Treatment?
Falk Kiefer, Holger Jahn, Christian Otte, Dieter
Naber and Klaus Wiedemann
Biological Psychiatry. Volume 60, Issue 1, 1 July 2006, Pages 74-76